Cargando…
Author Correction: Wogonin reversed resistant human myelogenous leukemia cells via inhibiting Nrf2 signaling by Stat3/ NF-κB inactivation
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196212/ https://www.ncbi.nlm.nih.gov/pubmed/34117343 http://dx.doi.org/10.1038/s41598-021-91964-z |
| _version_ | 1783706639053881344 |
|---|---|
| author | Xu, Xuefen Zhang, Xiaobo Zhang, Yi Yang, Lin Liu, Yicheng Huang, Shaoliang Lu, Lu Kong, Lingyi Li, Zhiyu Guo, Qinglong Zhao, Li |
| author_facet | Xu, Xuefen Zhang, Xiaobo Zhang, Yi Yang, Lin Liu, Yicheng Huang, Shaoliang Lu, Lu Kong, Lingyi Li, Zhiyu Guo, Qinglong Zhao, Li |
| author_sort | Xu, Xuefen |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8196212 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81962122021-06-15 Author Correction: Wogonin reversed resistant human myelogenous leukemia cells via inhibiting Nrf2 signaling by Stat3/ NF-κB inactivation Xu, Xuefen Zhang, Xiaobo Zhang, Yi Yang, Lin Liu, Yicheng Huang, Shaoliang Lu, Lu Kong, Lingyi Li, Zhiyu Guo, Qinglong Zhao, Li Sci Rep Author Correction Nature Publishing Group UK 2021-06-11 /pmc/articles/PMC8196212/ /pubmed/34117343 http://dx.doi.org/10.1038/s41598-021-91964-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Author Correction Xu, Xuefen Zhang, Xiaobo Zhang, Yi Yang, Lin Liu, Yicheng Huang, Shaoliang Lu, Lu Kong, Lingyi Li, Zhiyu Guo, Qinglong Zhao, Li Author Correction: Wogonin reversed resistant human myelogenous leukemia cells via inhibiting Nrf2 signaling by Stat3/ NF-κB inactivation |
| title | Author Correction: Wogonin reversed resistant human myelogenous leukemia cells via inhibiting Nrf2 signaling by Stat3/ NF-κB inactivation |
| title_full | Author Correction: Wogonin reversed resistant human myelogenous leukemia cells via inhibiting Nrf2 signaling by Stat3/ NF-κB inactivation |
| title_fullStr | Author Correction: Wogonin reversed resistant human myelogenous leukemia cells via inhibiting Nrf2 signaling by Stat3/ NF-κB inactivation |
| title_full_unstemmed | Author Correction: Wogonin reversed resistant human myelogenous leukemia cells via inhibiting Nrf2 signaling by Stat3/ NF-κB inactivation |
| title_short | Author Correction: Wogonin reversed resistant human myelogenous leukemia cells via inhibiting Nrf2 signaling by Stat3/ NF-κB inactivation |
| title_sort | author correction: wogonin reversed resistant human myelogenous leukemia cells via inhibiting nrf2 signaling by stat3/ nf-κb inactivation |
| topic | Author Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196212/ https://www.ncbi.nlm.nih.gov/pubmed/34117343 http://dx.doi.org/10.1038/s41598-021-91964-z |
| work_keys_str_mv | AT xuxuefen authorcorrectionwogoninreversedresistanthumanmyelogenousleukemiacellsviainhibitingnrf2signalingbystat3nfkbinactivation AT zhangxiaobo authorcorrectionwogoninreversedresistanthumanmyelogenousleukemiacellsviainhibitingnrf2signalingbystat3nfkbinactivation AT zhangyi authorcorrectionwogoninreversedresistanthumanmyelogenousleukemiacellsviainhibitingnrf2signalingbystat3nfkbinactivation AT yanglin authorcorrectionwogoninreversedresistanthumanmyelogenousleukemiacellsviainhibitingnrf2signalingbystat3nfkbinactivation AT liuyicheng authorcorrectionwogoninreversedresistanthumanmyelogenousleukemiacellsviainhibitingnrf2signalingbystat3nfkbinactivation AT huangshaoliang authorcorrectionwogoninreversedresistanthumanmyelogenousleukemiacellsviainhibitingnrf2signalingbystat3nfkbinactivation AT lulu authorcorrectionwogoninreversedresistanthumanmyelogenousleukemiacellsviainhibitingnrf2signalingbystat3nfkbinactivation AT konglingyi authorcorrectionwogoninreversedresistanthumanmyelogenousleukemiacellsviainhibitingnrf2signalingbystat3nfkbinactivation AT lizhiyu authorcorrectionwogoninreversedresistanthumanmyelogenousleukemiacellsviainhibitingnrf2signalingbystat3nfkbinactivation AT guoqinglong authorcorrectionwogoninreversedresistanthumanmyelogenousleukemiacellsviainhibitingnrf2signalingbystat3nfkbinactivation AT zhaoli authorcorrectionwogoninreversedresistanthumanmyelogenousleukemiacellsviainhibitingnrf2signalingbystat3nfkbinactivation |